ODDB.org: Open Drug Database | Drugs

|

|

|

|

|

|

Registration owner

|

Search result - 00640 - 01 - 004

Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension - 10 x 1

Swissmedic Key	00640004	Registration Holder	GlaxoSmithKline AG
Name	Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension	Date of registration	02.10.2000
		Introduction of Sequence	02.10.2000
ATC-Classification	Diphtheria-Haemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B (J07CA09)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	08.08.	Show package size	10 x 1
Index Therapeuticus (Swissmedic)	08.08.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680006400047	Medication Code	Impfstoffe
Pharmacode		Disponibility

Composition

I) DTPa-HepB-IPV: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.2 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80. II) Hib: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, aluminium 0.12 mg ut aluminii phosphas, pro praeparatione. I) et II) corresp. DTPa-HepB-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.32 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.

Packungsbestandteile

Label

II

Galenic Form

Injection suspension

Excipiens

BAG: Active Agent	Dose
Haemagglutinium Filamentosum (B. Pertussis)	25 mcg
Haemophilus Influenzae b Polysaccharida (Prp)	10 mcg
Pertactinum (B. Pertussis)	8 mcg
Toxoidum Diphtheriae	30 UI
Toxoidum Pertussis	25 mcg
Toxoidum Tetani	40 UI
Vaccinum Hepatitidis b (Adnr) Hbsag	10 mcg
Virus Poliomyelitis Typus 1 Inactivatum (Mahoney)	40 UI
Virus Poliomyelitis Typus 2 Inactivatum (Mef1)	8 UI
Virus Poliomyelitis Typus 3 Inactivatum (Saukett)	32 UI

Inactive agents	Dose
Aluminii Phosphas
Conjugata cum Toxoido Tetani	10 µg
Lactosum
Polysaccharida Haemophili Influenzae Typus B	20752

Label

I

Galenic Form

Injection suspension

Excipiens

Active Agent	Dose
Haemagglutininum Filamentosum (B. Pertussis)	25µg / 0.5ml
Hepatitidis b viri Antigenum Adnr	10µg / 0.5ml
Pertactinum (B. Pertussis)	8µg / 0.5ml
Toxoidum Diphtheriae	30U.I. / 0.5ml
Toxoidum Pertussis	25µg / 0.5ml
Toxoidum Tetani	40U.I. / 0.5ml
Virus Poliomyelitis Typus 1 Inactivatus (Mahoney)	40U.I. / 0.5ml
Virus Poliomyelitis Typus 2 Inactivatus (Mef1)	8U.I. / 0.5ml
Virus Poliomyelitis Typus 3 Inactivatus (Saukett)	32U.I. / 0.5ml

BAG: Active Agent	Dose
Haemagglutinium Filamentosum (B. Pertussis)	25 mcg
Haemophilus Influenzae b Polysaccharida (Prp)	10 mcg
Pertactinum (B. Pertussis)	8 mcg
Toxoidum Diphtheriae	30 UI
Toxoidum Pertussis	25 mcg
Toxoidum Tetani	40 UI
Vaccinum Hepatitidis b (Adnr) Hbsag	10 mcg
Virus Poliomyelitis Typus 1 Inactivatum (Mahoney)	40 UI
Virus Poliomyelitis Typus 2 Inactivatum (Mef1)	8 UI
Virus Poliomyelitis Typus 3 Inactivatum (Saukett)	32 UI

Inactive agents	Dose
Aluminii Hydroxidum Hydricum ad Adsorptionem
Aluminii Phosphas
Medium	199
Sodium Chloride

Source

Data was imported : 08.11.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH

|

|

|

|

|